- Home
- IMMR vs SCPH Comparison
IMMR vs SCPH Comparison
Compare IMMR & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMR
- SCPH
- Stock Information
- Founded
- IMMR 1993
- SCPH 2013
- Country
- IMMR United States
- SCPH United States
- Employees
- IMMR N/A
- SCPH N/A
- Industry
- IMMR Computer peripheral equipment
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- IMMR Technology
- SCPH Health Care
- Exchange
- IMMR Nasdaq
- SCPH Nasdaq
- Market Cap
- IMMR 247.2M
- SCPH 173.6M
- IPO Year
- IMMR 1999
- SCPH 2017
- Fundamental
- Price
- IMMR $7.85
- SCPH $4.51
- Analyst Decision
- IMMR Strong Buy
- SCPH Strong Buy
- Analyst Count
- IMMR 2
- SCPH 3
- Target Price
- IMMR $12.25
- SCPH $14.00
- AVG Volume (30 Days)
- IMMR 512.7K
- SCPH 261.6K
- Earning Date
- IMMR 08-19-2025
- SCPH 08-13-2025
- Dividend Yield
- IMMR 2.29%
- SCPH N/A
- EPS Growth
- IMMR 57.07
- SCPH N/A
- EPS
- IMMR 2.04
- SCPH N/A
- Revenue
- IMMR $163,133,000.00
- SCPH $41,982,000.00
- Revenue This Year
- IMMR $988.71
- SCPH $108.95
- Revenue Next Year
- IMMR $109.72
- SCPH $73.83
- P/E Ratio
- IMMR $3.84
- SCPH N/A
- Revenue Growth
- IMMR 338.21
- SCPH 138.10
- 52 Week Low
- IMMR $6.47
- SCPH $1.94
- 52 Week High
- IMMR $13.94
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- IMMR 52.63
- SCPH 60.01
- Support Level
- IMMR $7.62
- SCPH $3.83
- Resistance Level
- IMMR $8.00
- SCPH $4.18
- Average True Range (ATR)
- IMMR 0.20
- SCPH 0.17
- MACD
- IMMR -0.01
- SCPH -0.02
- Stochastic Oscillator
- IMMR 57.14
- SCPH 76.60
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.